JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32397

Anti-Caspase-8 antibody [E7]

  • 20ul selling size
  • KO Validated
  • RabMAb
  • Recombinant
  • What is this?

3

(2 Reviews)

|

(42 Publications)

Knockout Tested Rabbit Recombinant Monoclonal Caspase-8 antibody. Suitable for WB and reacts with Human samples. Cited in 42 publications.

View Alternative Names

MCH5, CASP8, Caspase-8, CASP-8, Apoptotic cysteine protease, Apoptotic protease Mch-5, CAP4, FADD-homologous ICE/ced-3-like protease, FADD-like ICE, ICE-like apoptotic protease 5, MORT1-associated ced-3 homolog, FLICE, MACH

6 Images
Western blot - Anti-Caspase-8 antibody [E7] (AB32397)
  • WB

Lab

Western blot - Anti-Caspase-8 antibody [E7] (AB32397)

Lanes 1 - 4 : Merged signal (red and green). Green - ab32397 observed at 55, 43/41 kDa. Red - loading control, ab9484, observed at 37 kDa.

ab32397 was shown to specifically react with HAP1 + Staurosproin when HAP1 + Staurosproin knockout samples were used. Wild-type and HAP1 + Staurosproin knockout samples were subjected to SDS-PAGE. ab32397 and ab9484 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1/500 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Caspase-8 antibody [E7] (ab32397) at 1/500 dilution

Lane 1:

Wild-type HAP1 whole cell lysate at 20 µg

Lane 2:

Wild-type HAP1 whole cell lysate treated with Staurosporin at 20 µg

Lane 3:

Caspase-8 knockout HAP1 whole cell lysate at 20 µg

Lane 4:

Caspase-8 knockout HAP1 whole cell lysate treated with Staurosporin at 20 µg

Predicted band size: 55 kDa

false

Western blot - Anti-Caspase-8 antibody [E7] (AB32397)
  • WB

Supplier Data

Western blot - Anti-Caspase-8 antibody [E7] (AB32397)

Blocking buffer and concentration : 5% NFDM/TBST.

Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Western blot - Anti-Caspase-8 antibody [E7] (ab32397) at 1/1000 dilution

Lane 1:

Jurkat cell lysate at 20 µg

Lane 2:

HeLa cell lysate at 20 µg

Lane 3:

IM-9 cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), HRP-conjugated at 1/1000 dilution

Predicted band size: 55 kDa

false

Western blot - Anti-Caspase-8 antibody [E7] (AB32397)
  • WB

Lab

Western blot - Anti-Caspase-8 antibody [E7] (AB32397)

Lanes 1- 4 : Merged signal (red and green). Green - ab32397 observed at 55 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.

ab32397 was shown to react with Caspase-8 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab264958 (knockout cell lysate ab256857) was used. Wild-type HeLa and CASP8 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab32397 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 500 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Caspase-8 antibody [E7] (ab32397) at 1/500 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

CASP8 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human CASP8 (Caspase-8) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-casp8-caspase-8-knockout-hela-cell-line-ab264958'>ab264958</a>)

Lane 3:

Jurkat cell lysate at 20 µg

Lane 4:

SH-SY5Y cell lysate at 20 µg

Predicted band size: 55 kDa

Observed band size: 55 kDa

false

Western blot - Anti-Caspase-8 antibody [E7] (AB32397)
  • WB

Lab

Western blot - Anti-Caspase-8 antibody [E7] (AB32397)

Western blot : Anti-CASP8 antibody [E7] (ab32397) staining at 1/500 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab32397 was shown to bind specifically to CASP8. A band was observed at 55 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in CASP8 knockout cell line. To generate this image, wild-type and CASP8 knockout HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-Caspase-8 antibody [E7] (ab32397) at 1/500 dilution

Lane 1:

Wild-type HCT 116 cell lysate at 20 µg

Lane 2:

CASP8 knockout HCT 116 cell lysate at 20 µg

Lane 3:

Wild-type HeLa cell lysate at 20 µg

Lane 4:

CASP8 knockout HeLa cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

false

Western blot - Anti-Caspase-8 antibody [E7] (AB32397)
  • WB

Unknown

Western blot - Anti-Caspase-8 antibody [E7] (AB32397)

All lanes:

Western blot - Anti-Caspase-8 antibody [E7] (ab32397) at 1/500 dilution

All lanes:

HeLa cell lysate at 10 µg

Predicted band size: 55 kDa

Observed band size: 55 kDa

false

Western blot - Anti-Caspase-8 antibody [E7] (AB32397)
  • WB

Lab

Western blot - Anti-Caspase-8 antibody [E7] (AB32397)

Western blot : Anti-Caspase-8 antibody [E7] ab32397 staining at 1/500 dilution, shown in green; Mouse anti GAPDH (ab8245) loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 60 kDa in Wild-type A549 cell lysates with no signal observed at this size in CASP8 knockout A549 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-Caspase-8 antibody [E7] (ab32397) at 1/500 dilution

Lane 1:

Wild-type A549 at 20 µg

Lane 2:

Western blot - Human CASP8 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-casp8-knockout-a549-cell-line-ab286757'>ab286757</a>) at 20 µg

Lane 3:

Western blot - Human wild-type HCT116 cell line (ab288559) at 20 µg

Lane 4:

Western blot - Human CASP8 knockout HCT116 cell line (<a href='/en-us/products/cell-lines/human-casp8-knockout-hct116-cell-line-ab286576'>ab286576</a>) at 20 µg

Secondary

Lanes 1 - 4:

Goat anti-Rabbit 800CW at 1/20000 dilution

Lanes 1 - 4:

Goat anti-Mouse 680RD at 1/20000 dilution

Predicted band size: 60 kDa

Observed band size: 60 kDa,37 kDa

false

  • Carrier free

    Anti-Caspase-8 antibody [E7] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

E7

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

The antibody should recognize both pro-form (55kDa) and p18 cleaved-form of Caspase-8.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p><strong>For unpurified use at 1/500.</strong></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }

Product details

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Thiol protease that plays a key role in programmed cell death by acting as a molecular switch for apoptosis, necroptosis and pyroptosis, and is required to prevent tissue damage during embryonic development and adulthood (PubMed : 23516580, PubMed : 35338844, PubMed : 35446120, PubMed : 8681376, PubMed : 8681377, PubMed : 8962078, PubMed : 9006941, PubMed : 9184224). Initiator protease that induces extrinsic apoptosis by mediating cleavage and activation of effector caspases responsible for FAS/CD95-mediated and TNFRSF1A-induced cell death (PubMed : 23516580, PubMed : 35338844, PubMed : 35446120, PubMed : 8681376, PubMed : 8681377, PubMed : 8962078, PubMed : 9006941, PubMed : 9184224). Cleaves and activates effector caspases CASP3, CASP4, CASP6, CASP7, CASP9 and CASP10 (PubMed : 16916640, PubMed : 8962078, PubMed : 9006941). Binding to the adapter molecule FADD recruits it to either receptor FAS/TNFRSF6 or TNFRSF1A (PubMed : 8681376, PubMed : 8681377). The resulting aggregate called the death-inducing signaling complex (DISC) performs CASP8 proteolytic activation (PubMed : 9184224). The active dimeric enzyme is then liberated from the DISC and free to activate downstream apoptotic proteases (PubMed : 9184224). Proteolytic fragments of the N-terminal propeptide (termed CAP3, CAP5 and CAP6) are likely retained in the DISC (PubMed : 9184224). Also cleaves and activates BID, thereby promoting cytochrome C release from mitochrondria (By similarity). In addition to extrinsic apoptosis, also acts as a negative regulator of necroptosis : acts by cleaving RIPK1 at 'Asp-324', which is crucial to inhibit RIPK1 kinase activity, limiting TNF-induced apoptosis, necroptosis and inflammatory response (PubMed : 31827280, PubMed : 31827281). Also able to initiate pyroptosis by mediating cleavage and activation of gasdermin-C and -D (GSDMC and GSDMD, respectively) : gasdermin cleavage promotes release of the N-terminal moiety that binds to membranes and forms pores, triggering pyroptosis (PubMed : 32929201, PubMed : 34012073). Initiates pyroptosis following inactivation of MAP3K7/TAK1 (By similarity). Also acts as a regulator of innate immunity by mediating cleavage and inactivation of N4BP1 downstream of TLR3 or TLR4, thereby promoting cytokine production (By similarity). May participate in the Granzyme B (GZMB) cell death pathways (PubMed : 8755496). Cleaves PARP1 and PARP2 (PubMed : 8681376). Independent of its protease activity, promotes cell migration following phosphorylation at Tyr-380 (PubMed : 18216014, PubMed : 27109099).. Isoform 5. Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex.. Isoform 6. Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex.. Isoform 7. Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex (Probable). Acts as an inhibitor of the caspase cascade (PubMed : 12010809).. Isoform 8. Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex.
See full target information CASP8

Publications (42)

Recent publications for all applications. Explore the full list and refine your search

Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 44:31-39 PubMed40493899

2025

lncRNA PTCSC1 Promotes TRAIL Resistance through FOXO3a Pathway in HCT116 and SW480 Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Changcheng Wang,Jia Guo,Zengan Wu

Veterinary research 55:156 PubMed39614405

2024

Porcine parvovirus infection induces necroptosis of porcine placental trophoblast cells via a ZBP1-mediated pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Ning Xu,Qian Du,Yijiao Cheng,Lichen Nie,Peipei Ma,Dingwen Feng,Yong Huang,Dewen Tong

Cardiology research and practice 2024:1905996 PubMed39257436

2024

Inhibiting H2AX Can Ameliorate Myocardial Ischemia/Reperfusion Injury by Regulating P53/JNK Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Ziyang Yu,Yirong Teng,Hongbo Yang,Yudi Wang,Xichen Li,Lei Feng,Wenbo Xu,Yinglu Hao,Yanping Li

European journal of medical research 29:405 PubMed39103890

2024

Anticancer effects of Erzhimaoling decoction in high-grade serous ovarian cancer in vitro and in vivo.

Applications

Unspecified application

Species

Unspecified reactive species

Li Yang,Jingfang Liu,Jiejie Zhang,Feng Shao,Yanlu Jin,Jie Xing,Heran Zhou,Aijun Yu

PLoS pathogens 19:e1011892 PubMed38157331

2024

Pathogen-driven nucleotide overload triggers mitochondria-centered cell death in phagocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Nicoletta Schwermann,Rita Haller,Sebastian Koch,Guntram A Grassl,Volker Winstel

Scientific reports 13:23067 PubMed38155283

2023

Optogenetic induction of caspase-8 mediated apoptosis by employing Arabidopsis cryptochrome 2.

Applications

Unspecified application

Species

Unspecified reactive species

Weiliang Mo,Shengzhong Su,Ruige Shang,Liang Yang,Xuelai Zhao,Chengfeng Wu,Zhenming Yang,He Zhang,Liuming Wu,Yibo Liu,Yun He,Ruipeng Zhang,Zecheng Zuo

Aging and disease 14:1799-1817 PubMed37196118

2023

TAK1 Improves Cognitive Function via Suppressing RIPK1-Driven Neuronal Apoptosis and Necroptosis in Rats with Chronic Hypertension.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Yang,Pei Sun,Xiangming Xu,Xiaolu Liu,Linfang Lan,Ming Yi,Chi Xiao,Ruichen Ni,Yuhua Fan

Cancers 15: PubMed37173953

2023

Genome-Wide Screening Identifies Gene AKR1C1 Critical for Resistance to Pirarubicin in Bladder Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenyu Nie,Yuanhui Gao,Mei Chen,Yanling Peng,Na Guo,Hui Cao,Denggao Huang,Xin Gao,Shufang Zhang

International journal of molecular medicine 50: PubMed35775376

2022

Lamin B2 contributes to the proliferation of bladder cancer cells via activating the expression of cell division cycle‑associated protein 3.

Applications

Unspecified application

Species

Unspecified reactive species

Junpeng Ji,Huibing Li,Jing Chen,Wenjun Wang

Oncology reports 48: PubMed35730618

2022

induces growth inhibition and autophagy‑related apoptosis by regulating the AMPK and Akt/mTOR/p70S6K signaling pathways in cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Weixiao An,Yuxi Zhang,Honglin Lai,Yangyang Zhang,Hongmei Zhang,Ge Zhao,Minghua Liu,Yang Li,Xiukun Lin,Shousong Cao
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com